Gilbert & Cook’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.86M | Sell |
7,382
-68
| -0.9% | -$14.6K | 0.21% | 41 |
|
|
2026
Q1 | $1.62M | Buy |
7,450
+164
| +2% | +$36.4K | 0.21% | 39 |
|
|
2025
Q4 | $1.66M | Sell |
7,286
-364
| -5% | -$82.9K | 0.21% | 40 |
|
|
2025
Q3 | $1.77M | Sell |
7,650
-66
| -0.9% | -$13.4K | 0.23% | 37 |
|
|
2025
Q2 | $1.43M | Buy |
7,716
+252
| +3% | +$46.8K | 0.19% | 47 |
|
|
2025
Q1 | $1.56M | Sell |
7,464
-1,645
| -18% | -$320K | 0.23% | 34 |
|
|
2024
Q4 | $1.62M | Sell |
9,109
-84
| -0.9% | -$15.4K | 0.23% | 37 |
|
|
2024
Q3 | $1.82M | Buy |
9,193
+1,132
| +14% | +$211K | 0.25% | 31 |
|
|
2024
Q2 | $1.38M | Sell |
8,061
-609
| -7% | -$101K | 0.2% | 37 |
|
|
2024
Q1 | $1.58M | Sell |
8,670
-1,021
| -11% | -$176K | 0.22% | 42 |
|
|
2023
Q4 | $1.5M | Buy |
9,691
+861
| +10% | +$126K | 0.21% | 36 |
|
|
2023
Q3 | $1.32M | Buy |
8,830
+452
| +5% | +$66.4K | 0.21% | 39 |
|
|
2023
Q2 | $1.13M | Buy |
8,378
+318
| +4% | +$46.6K | 0.18% | 42 |
|
|
2023
Q1 | $1.28M | Buy |
8,060
+65
| +0.8% | +$9.94K | 0.22% | 34 |
|
|
2022
Q4 | $1.29M | Sell |
7,995
-103
| -1% | -$15.8K | 0.24% | 34 |
|
|
2022
Q3 | $1.17M | Buy |
8,098
+136
| +2% | +$19.5K | 0.26% | 38 |
|
|
2022
Q2 | $1.22M | Buy |
7,962
+462
| +6% | +$70.6K | 0.22% | 35 |
|
|
2022
Q1 | $1.22M | Buy |
7,500
+179
| +2% | +$26K | 0.2% | 39 |
|
|
2021
Q4 | $991K | Buy |
7,321
+2,303
| +46% | +$272K | 0.16% | 50 |
|
|
2021
Q3 | $541K | Buy |
5,018
+175
| +4% | +$20K | 0.1% | 95 |
|
|
2021
Q2 | $546K | Buy |
4,843
+96
| +2% | +$10.8K | 0.1% | 86 |
|
|
2021
Q1 | $514K | Buy |
4,747
+497
| +12% | +$53.2K | 0.1% | 86 |
|
|
2020
Q4 | $457K | Sell |
4,250
-4,627
| -52% | -$445K | 0.1% | 83 |
|
|
2020
Q3 | $778K | Buy |
8,877
+434
| +5% | +$40.9K | 0.18% | 43 |
|
|
2020
Q2 | $829K | Buy |
8,443
+1,717
| +26% | +$151K | 0.21% | 42 |
|
|
2020
Q1 | $512K | Buy |
6,726
+935
| +16% | +$79.6K | 0.15% | 49 |
|
|
2019
Q4 | $513K | Buy |
5,791
+3,054
| +112% | +$254K | 0.13% | 58 |
|
|
2019
Q3 | $207K | Buy |
+2,737
| New | +$188K | 0.06% | 115 |
|
|
2018
Q1 | – | Sell |
-2,290
| Closed | -$221K | – | 93 |
|
|
2017
Q4 | $221K | Buy |
+2,290
| New | +$216K | 0.08% | 81 |
|
|
2017
Q3 | – | Sell |
-4,601
| Closed | -$333K | – | 85 |
|
|
2017
Q2 | $333K | Buy |
+4,601
| New | +$309K | 0.12% | 87 |
|
Other funds holding ABBV
Gilbert & Cook's ABBV Position: Q2 2026 in Review
Gilbert & Cook reduced its AbbVie (ABBV) stake by 0.91% in Q2 2026, selling an estimated $14.6K and leaving 7,382 shares worth $1.86M. The position accounts for 0.21% of the portfolio, ranked #41.
Gilbert & Cook first reported a position in ABBV in Q2 2017 and has held it in 30 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Gilbert & Cook held 7,382 shares of AbbVie worth $1.86M as of Q2 2026.
- Gilbert & Cook sold 68 AbbVie shares in Q2 2026, an estimated $14.6K.
- AbbVie made up 0.21% of Gilbert & Cook's portfolio in Q2 2026, its #41 holding.
- Gilbert & Cook first reported a position in AbbVie in Q2 2017 and has held it in 30 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.